Corneal cell implant for corneal swelling
This trial tests a new treatment that implants donated corneal cells attached to a tiny gel onto the back of the cornea. It aims to reduce swelling and improve vision in people with corneal conditions like Fuchs dystrophy or swelling after cataract surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 21 years old.
- You must have Fuchs dystrophy or corneal swelling after cataract surgery (pseudophakic bullous keratopathy).
- You must be willing to have eye surgery and attend follow-up visits.
- You must not have other significant eye problems besides the corneal swelling (like uncomplicated cataract surgery).
- You must not have corneal scarring that would make standard endothelial keratoplasty surgery unsuitable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This trial tests an investigational cell therapy called EO2002 for people with corneal edema (swelling of the clear front part of the eye) caused by endothelial dysfunction, which can happen with Fuchs dystrophy or after cataract surgery. The treatment aims to restore the inner layer of the cornea to reduce swelling and improve vision.
This trial tests a simple cell treatment for a swollen cornea caused by cataract surgery. It aims to help your cornea become clear again without a full transplant.
This Phase 1 trial tests a new, lab-made tissue transplant to improve corneal clarity in people with certain types of corneal endothelium failure (eye swelling) caused by specific conditions. The main goal is to check safety and see if vision and corneal health improve.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This study tests an artificial corneal implant called EndoArt for people with long-term corneal swelling who have run out of transplant options. The implant aims to reduce swelling and improve vision without needing a donor cornea.
Hear when a new Corneal Endothelial Cell Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.